MedDeviceGuideMedDeviceGuide

MedDeviceGuide — IVD & Medical Device Knowledge Base

Regulatory

Canada MDALL Class III/IV Analysis: US Companies Hold 48% of High-Risk Listings

US companies hold 48% of Canada's 57,000 Class III/IV MDALL listings. Median device age is 9.7 years and 49% of devices are over a decade old. Full data analysis.

EU MDR / IVDR

EU AI Act High-Risk Classification Guidelines for Medical Device Manufacturers

EU Commission's May 2026 draft Article 6 high-risk AI classification guidelines: two-path system for medical devices, consultation deadline June 23, and compliance deadlines in 2027-2028.

Regulatory

FDA 510(k) Exemptions for Unclassified Devices: June 2026 Guidance Update

FDA's June 5, 2026 guidance adds five unclassified device product codes to the 510(k) exemption list. Covers all 13 codes, enforcement policy, remaining obligations, and next steps.

Regulatory

KIMES 2026: 977 Exhibitors, 78% Korean, Surgical Leads — Korea Export Push

KIMES 2026 exhibitor analysis: 977 companies, 78% Korean, surgical devices lead at 259 exhibitors, 94% export-ready. China tops international pavilion with 81 companies.

Regulatory

Korea MFDS: J&J, Medtronic, Stryker Dominate High-Risk Device Imports

Korea MFDS data shows 13,117 licence holders manage 273,672 registrations. Top 20 holders control 14.4%. US firms dominate Class III/IV imports at 30.4%.

Regulatory

Malaysia MDA: 2,462 Establishments, 23% Expiry Cliff, J&J at 58% Renewal

Malaysia MDA 49,198-row device dataset reveals 2,462 establishments with top-20 concentration at 18.7% and 11,438 devices expiring by end 2027. Data-driven establishment selection insights.

Cybersecurity

Medical Device Cybersecurity Is Now a Procurement Gate: 2026 Hospital Buying Data

RunSafe's 2026 Index: 56% of hospitals reject devices over cybersecurity, 35% won't buy without an SBOM, and 84% include security in RFPs. What manufacturers must do now.

Regulatory

Mexico COFEPRIS Registration Holders: 5,286 Holders and the 2024 Volume Surge

Analysis of Mexico's 16,473 COFEPRIS registrations reveals 5,286 holders, 60% single-registration, diagnostics dominance at 37%, and a 2024 record peak.

Regulatory

Qatar's 2,623 Implantable Devices: 62% in 20 Suppliers, Lebanese Lock-In

Qatar MoPH implantable device register: 2,623 devices, 171 suppliers, top 20 control 62%. Lebanese distributor dominance and single-supplier manufacturer lock-in analyzed.

Regulatory

Saudi SFDA AR Concentration: 1,608 ARs, 35% in 20 Hands, 13,700 Expiry Cliff

Saudi SFDA 56,737-row device database: 1,608 ARs, top-20 concentration at 35.4%, and 13,717 devices expiring 2026-2027. Data-driven AR selection insights.

Regulatory

UAE EDE: 10 Suppliers Control a Third of All Medical Device Registrations

UAE EDE data shows 10 suppliers control 33.7% of 4,793 medical device registrations. Cigalah, Pharmatrade lead. US tops country of origin at 16%. Dubai holds 63.5% of registrations.

Regulatory

FDA 510(k) Application: Submission Components and Format Requirements

Every section of an FDA 510(k) application explained — cover sheet, indications for use, device description, SE discussion, testing, labeling, software, and the eSTAR template structure.

Regulatory

FDA 510(k) K-Number: How to Decode It, Find It, and Use It for Regulatory Intelligence

What the 510(k) K-number means, how the format encodes the year and sequence, and how regulatory professionals use K-numbers for predicate research, competitor tracking, and submission management.

Quality Systems

ISO 13485 Audit Findings: Most Common Nonconformities by Clause and How to Prevent Them

The ISO 13485 clauses most cited in audit findings — root causes and corrective actions for document control, CAPA, design controls, suppliers, internal audits, and process validation.

Regulatory

FDA 510(k) Consultants: How to Choose, Vet, and Work with a Clearance Partner

How to select, evaluate, and engage an FDA 510(k) consultant — fees by device complexity, engagement models, red flags, due diligence checklist, and when hiring one makes financial sense.

Regulatory

FDA Adverse Event Monitoring System (AEMS): What Replaced MAUDE for Medical Devices

FDA replaces MAUDE with AEMS — unified adverse event dashboard, migration timeline, data limitations, and reporting changes for device manufacturers.

Quality Systems

Medical Device Software Verification vs Validation: FDA and IEC 62304 Requirements

Software verification vs validation for medical devices — FDA expectations, IEC 62304 activities, documentation, traceability, and the design control process.

Regulatory

FDA 510(k) Clearances: Tracking, Timelines, and Decision Data

Track FDA 510(k) clearances, understand review timelines, interpret SE/NSE decisions, use the 510(k) database, and apply clearance statistics to your 2026 regulatory strategy.

Regulatory

FDA 510(k) Guidance Documents: Device-Specific Requirements and Special Controls

How to find and use FDA 510(k) guidance documents, Class II special controls, device-specific submission requirements, and the CDRH FY 2026 guidance agenda to prepare stronger premarket submissions.

Regulatory

FDA Medical Device Registration: Step-by-Step Process from Classification to Market

Step-by-step FDA medical device registration — classification, 510(k)/De Novo/PMA pathways, establishment registration, device listing, FY 2026 fees, and post-market obligations.